VALPROIC ACID (valproic acid) by Catalent. Approved for anti-epileptic agent [epc]. First approved in 1991.
Drug data last refreshed 3d ago
Anti-epileptic Agent
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Valproic AcId for Traumatic BRAin INjury Trial
A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants
Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Trauma Patients
Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients
Study to Evaluate the Effect of UGT Inhibition by Valproic Acid on the Pharmacokinetics of BIIB074
Worked on VALPROIC ACID at Catalent? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.